REQUEST A DEMO
Total
USD $0.00
Search more companies

Smart Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Smart Pharma Sp. z o.o. Profile Updated: March 06, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Smart Pharma Sp. z o.o. is a company in Poland, with a head office in Zlotniki. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on February 09, 2015. The total number of employees is currently 10 (2015). In 2020, the company reported a net sales revenue drop of 14.01%. Its total assets grew by 2.16% over the same period. In, 2020, the company’s net profit margin decreased by 5.53%.

Headquarters
Ul. Kobaltowa 6
Zlotniki; Wielkopolskie; Postal Code: 62-002

Contact Details: Purchase the Smart Pharma Sp. z o.o. report to view the information.

Website: http://www.smartpharma.com.pl

Basic Information
Total Employees:
Purchase the Smart Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Smart Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Smart Pharma Sp. z o.o. report to view the information.
Incorporation Date:
February 09, 2015
Key Executives
Company Performance
Financial values in the chart are available after Smart Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-14.01%
Total operating revenue
-13.61%
Operating profit (EBIT)
-36.46%
Net Profit (Loss) for the Period
-36.39%
Total assets
2.16%
Total equity
-21.77%
Operating Profit Margin (ROS)
-6.92%
Net Profit Margin
-5.53%
Return on Equity (ROE)
-11.18%
Quick Ratio
-2.83%
Cash Ratio
-1.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?